Cyrano Therapeutics

CYR-064 Controlled Trial

Smell Loss
Clinical Trial

Condition: Hyposmia

A Randomized, Double-Blinded, Placebo-Controlled Trial to Determine The Safety and Efficacy of CYR-064

The purpose of this study is to determine the safety and effectiveness of CYR-064 in a randomized, double-blinded, placebo-controlled trial to determine the safety and efficacy of CYR064.

The study will take approximately 32 weeks which will include a 4-week screening period to evaluate if participants are right for the Study, followed by a 24-week Treatment Period, and a 1 week follow up after participants have completed the Study. About 150 subjects will participate in this study in about 25 research sites in the United States.

ACTIVELY ENROLLING SMELL LOSS TRIAL

A Groundbreaking Smell Loss Clinical Trial

Explore the potential benefits of participating in our Smell Loss Clinical Trial with CYR-064, a groundbreaking study that aims to redefine the treatment landscape for smell loss. 

This randomized, double-blinded, placebo-controlled trial is designed to assess the safety and efficacy of CYR-064 in treating taste dysfunction. Participants have the unique opportunity to access cutting-edge treatments and contribute to medical research that could lead to new solutions for those suffering from smell loss. Our dedicated team ensures thorough monitoring and support throughout the study, ensuring the highest standards of care.

Cyrano Therapeutics Smell Recovery

Are You Interested in Contributing to a Major Advancement in Smell Loss Treatment?

Join our Smell Loss Clinical Trial of CYR-064 while positions are still available! This is your chance to be part of a leading-edge study that not only offers potential personal health benefits but also contributes to broader medical advancements. Don’t miss out on this opportunity to participate in a pivotal research effort.

Apply now to secure your place in this important trial, and take an active role in shaping the future of taste dysfunction treatment.

Clinical Smell Loss Study Sites by Location

Chicago

 RUSH University Medical Center – Chicago, IL

Colorado

Colorado ENT and Allergy – Colorado Springs, CO

Florida

ENT AA Florida ( 3 clinical site locations)

Kansas

Kentucky

Kentuckiana ENT – Louisville, KY

Advanced ENT and Allergy –  Louisville, KY

Louisiana 

 Tandem Clinical Research – Marrero, LA

Maryland

Pennsylvania 

Specialty Physician Associates – Bethlehem, PA

South Carolina

Charleston ENT North – Charleston, SC

Texas

Houston Methodist – Houston, TX

Washington

ENT and Allergy Associates – Puyallup, WA